# Safety Assessment of Atomoxetine With MA IV Administration

> **NCT01019707** · PHASE1 · TERMINATED · sponsor: **University of California, Los Angeles** · enrollment: 6 (actual)

## Conditions studied

- Methamphetamine Abuse
- Methamphetamine Dependence

## Interventions

- **DRUG:** Atomoxetine, then Placebo
- **DRUG:** Placebo, then Atomoxetine

## Key facts

- **NCT ID:** NCT01019707
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** End in funding
- **Last updated:** 2017-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01019707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01019707, "Safety Assessment of Atomoxetine With MA IV Administration". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01019707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*